HIGHLIGHTS
- who: Jorge Castillo-Arellano and colleagues from the Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA have published the article: The Polypharmacological Effects of Cannabidiol, in the Journal: Molecules 2023, 28, x FOR PEER REVIEW of /2023/
- what: In this Article a rationalized integration of the mechanisms of action of CBD on molecular targets and pharmacological implications in animal models and human diseases such as epilepsy pain neuropsychiatric disorders Alzheimer`s disease and inflammatory diseases are presented. Most of the research groups dedicated to cannabinoids are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.